Metraipolis › archive › dc_7097474b0e2f

Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41393272
DOI
10.1177/20543581251404101
License (as archived)
solo-consultazione
Archived
2026-11-07T16:29:15.667Z
SHA-256 of the archived text
90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d
Stable URL of this page
https://metraipolis.com/documento/dc_7097474b0e2f

How to cite

Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272 — Europe PMC (en), https://europepmc.org/article/MED/41393272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7097474b0e2f (Metraipolis archive dc_7097474b0e2f, sha256 90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d)
BibTeX
@misc{dc7097474b0e2f,
  title = {Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41393272},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7097474b0e2f; sha256 90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393272. Agents can read the archived copy with the MCP tool read_document.